Ronak Chokhani

Photo of Ronak Chokhani

Ronak Chokhani practices in Stoel Rives’ Corporate group, where he focuses on health care transactions. He provides guidance on a wide range of regulatory and corporate transactional matters to medical groups, managed care companies, and other health care entities. Ronak’s business acumen and passion for the health care industry coupled with his distinguished legal research and writing skills make him an asset for his clients. He constantly strives to increase the breadth and depth of his legal knowledge to ensure his clients receive sound legal guidance.

Click here for Ronak Chokhani’s full bio.

Subscribe to all posts by Ronak Chokhani

New Proposed Part 2 Rules Aim for Greater HIPAA Alignment

By Kelly Knivila and Ronak Chokhani on Posted in Data Privacy and Security, HIPAA, Legal Updates
Long before enactment of HIPAA, substance use disorder (“SUD”) treatment records have enjoyed confidentiality protections under 42 C.F.R. Part 2 (“Part 2”). Since HIPAA/HITECH and related regulations went into effect, SUD treatment providers that are subject to Part 2 (“Part 2 programs”) have struggled to make sense of the inconsistencies between Part 2 and HIPAA. … Continue Reading

Department of Health (“DOH”) Has Issued Material Updates to Rules Governing Coordinated Quality Improvement Program (“CQIP”) Approval

By Ronak Chokhani and Terri Rambosek on Posted in Legal Updates
Many health care entities took a “set it and forget it” approach to their CQIPs once the CQIPs were approved by DOH under regulations adopted in 2006.  Beginning tomorrow, such entities will need to reconsider their approach.  DOH has published significant changes to its regulations regarding approval of CQIPs that are operated by health care … Continue Reading

Non-Urgent and Elective Procedures Update: Oregon and Washington Ease Prohibitions

By Kelly Knivila and Ronak Chokhani on Posted in COVID-19, Oregon, Washington
In a previous Health Law Insider blog post, Stoel Rives’ health care team discussed the prohibition on elective procedures promulgated by Oregon and Washington in an effort to conserve the states’ supply of Personal Protective Equipment (“PPE”) and manage provider treatment capacity to ensure adequate resources were available to combat COVID-19. Recently, Oregon and Washington … Continue Reading

COVID-19 Update: FCC Accepting Applications for Its $200M Telehealth Program; Red Light Rule Waived

By Ronak Chokhani and Timothy Hatfield on Posted in COVID-19, Reimbursement, Telehealth
In a previous client alert, Stoel Rives’ health care team provided responses to certain frequently asked questions regarding the Federal Communications Commission’s (“FCC”) COVID-19 Telehealth Program (“Program”). At the time of that earlier client alert, FCC was awaiting the Office of Management & Budget’s approval of the Program application (“Application”) before beginning the application process. … Continue Reading

COVID 19 Update: Minnesota’s Ban on Elective Procedures, Providers May Be Compelled to Donate or Sell Medical Equipment

By Ronak Chokhani and Laurie Huotari on Posted in COVID-19, Minnesota
In a previous blog post, Stoel Rives’ health care team discussed orders issued by Washington and Oregon that banned elective procedures in an effort to preserve the states’ supply of certain medical equipment. Minnesota has issued similar orders to ensure its healthcare facilities have adequate capacity and medical equipment to treat COVID-19 patients. After banning … Continue Reading

FCC Releases $200M COVID-19 Telehealth Program Guidance: Your Questions Answered

By Timothy Hatfield and Ronak Chokhani on Posted in COVID-19, Reimbursement
On April 2, 2020, the Federal Communications Commission (“FCC”) released its Report and Order 20-44 outlining how it plans to distribute $200 million appropriated to it by the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). The COVID-19 Telehealth Program (the “Program”) will allow eligible providers to be reimbursed for “telecommunication services, information … Continue Reading

Desperate Times, Desperate Measures: Elective Medical Procedures Banned, PPEs at Risk of Confiscation

By Kelly Knivila and Ronak Chokhani on Posted in COVID-19, Legal Updates, Oregon, Washington
In an effort to conserve the state’s medical supplies and equipment, specifically personal protective equipment (PPE), Washington and Oregon (among other states) have banned non-urgent, elective procedures.[1] A move that the states hope will help ensure adequate supply of PPE and other medical equipment (e.g., ventilators) to address the COVID-19 pandemic. Here is a comparative … Continue Reading

COVID-19 Leads to Liberalization of e-Prescribing of Controlled Substances, May Presage Permanent Rulemaking

By Ronak Chokhani and Timothy Hatfield on Posted in COVID-19, Legal Updates, National
In light of the COVID-19 pandemic, the Drug Enforcement Agency (“DEA”) recently issued guidance permitting the use of telemedicine to prescribe controlled substances (schedule II to V) for the duration of the public health emergency declared by the Secretary of Health and Human Services. Specifically, if (a) the prescription “is issued for a legitimate medical … Continue Reading

AKS and Medicare Advantage Plans: Don’t Kickback and Relax!

By Timothy Hatfield and Ronak Chokhani on Posted in AKS, Medicare
Health care attorneys have long questioned whether there are significant Anti-Kickback Statute (AKS) risks associated with financial transactions between Medicare Advantage plans and their participating providers. An ongoing case in the Northern District of Illinois could provide Medicare Advantage organizations with a clear answer regarding the nature of such risks. United States ex rel. Derrick … Continue Reading
LexBlog